Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
francesco.panzuto@uniroma1.it
Francesco Panzuto
Professore Associato
Struttura:
DIPARTIMENTO DI SCIENZE MEDICO-CHIRURGICHE E DI MEDICINA TRASLAZIONALE
E-mail:
francesco.panzuto@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Therapy of NET with radiolabeled SST analogs
Nuclear Medicine and Molecular Imaging
2022
Il valore aggiunto della RLT: che cosa insegna l’esperienza clinica nei tumori neuroendocrini.
La terapia con radioligandi in oncologia
2022
Comparison of Endoscopic Techniques in the Management of Type I Gastric Neuroendocrine Neoplasia: A Systematic Review
GASTROENTEROLOGY RESEARCH AND PRACTICE
2021
Second primary neoplasms in patients with lung and gastroenteropancreatic neuroendocrine neoplasms: data from a retrospective multi-centric study
DIGESTIVE AND LIVER DISEASE
2021
Management of type-I gastric neuroendocrine neoplasms. A 10-years prospective single centre study
DIGESTIVE AND LIVER DISEASE
2021
Exocrine pancreatic insufficiency and somatostatin analogs in patients with neuroendocrine neoplasia
EXPERT OPINION ON DRUG SAFETY
2021
Efficacy of lutetium-peptide receptor radionuclide therapy in inducing prolonged tumour regression in small-bowel veuroendocrine tumours. A case of favourable response to retreatment after Initial objective response
ONCOLOGY RESEARCH AND TREATMENT
2021
Octreotide long-acting release (LAR) in combination with other therapies for treatment of neuroendocrine neoplasia. A systematic review
JOURNAL OF GASTROINTESTINAL ONCOLOGY
2021
Tumor heterogenity in gastro-entero-pancreatic neuroendocrine neoplasia
ENDOCRINES
2021
Reply to Dr. Hall and coworkers
EXPERT OPINION ON DRUG SAFETY
2021
Bone Metastases in Neuroendocrine Tumors. Molecular Pathogenesis and Implications in Clinical Practice
NEUROENDOCRINOLOGY
2021
Clinical challenges in the management of neuroendocrine tumors
JOURNAL OF CLINICAL MEDICINE
2021
Risk of preoperative understaging of duodenal neuroendocrine neoplasms. a plea for caution in the treatment strategy
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
2021
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet)
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
2021
Sporadic non-functioning pancreatic neuroendocrine tumours. multicentre analysis
BRITISH JOURNAL OF SURGERY
2021
Efficacy and safety of high-dose lanreotide autogel in patients with progressive pancreatic or midgut neuroendocrine tumours. CLARINET FORTE phase 2 study results
EUROPEAN JOURNAL OF CANCER
2021
MYC Upregulation Confers Resistance to Everolimus and Establishes Vulnerability to Cyclin-Dependent Kinase Inhibitors in Pancreatic Neuroendocrine Neoplasm Cells
NEUROENDOCRINOLOGY
2021
Treatment of Intestinal NETs (Including Appendix)
Neuroendocrine neoplasia management. New Approaches for Diagnosis and Treatment
2021
CT texture analysis of liver metastases in PNETs versus NPNETs: correlation with histopathological findings
EUROPEAN JOURNAL OF RADIOLOGY
2020
Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine Tumor
THE JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
2020
« prima
< precedente
1
2
3
4
5
6
seguente ›
ultima »
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma